The week in health tech, explained in plain English.Get the free newsletter →
October 15, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

Pharmacy Groups Warn Revised ACIP Charter Could Delay Vaccines

Nine pharmacy organizations sent a July 9 letter to HHS Secretary Robert F. Kennedy Jr. warning that the CDC's June 25 revised charter for the Advisory Committee on Immunization Practices could undermine the evidence-based framework that has long guided U.S. immunization policy, according to Becker's Hospital Review.

The letter caps a yearlong restructuring of ACIP, the expert panel whose recommendations determine which vaccines are covered by insurers, stocked by pharmacies, and administered to patients. The groups argue that changes to how the committee operates could slow the process for reviewing and recommending vaccines, delaying access for patients who rely on pharmacies as a primary point of care.

Because ACIP recommendations flow directly into insurance coverage rules and pharmacy protocols, any disruption ripples across the delivery system. Pharmacists, who administer a large share of routine and seasonal vaccines, would feel the effects first. The organizations are pressing HHS to preserve the committee's scientific independence and transparent review process.

More in Government

Government

Pennsylvania Sues Insulin Makers and PBMs Over Pricing

Pennsylvania's attorney general sued three insulin makers and several PBMs, alleging they colluded to manipulate insulin prices and raise patient costs.

Why it matters: The case adds to mounting legal pressure on insulin pricing and PBM rebate practices that determine what diabetic patients pay at the pharmacy.

Government

CMS Shaped AI Health Policy in a Private Slack

A KFF Health News investigation found CMS used a 1,700-member Slack of tech executives and investors to help shape federal AI healthcare policy outside public channels.

Why it matters: Federal AI rules will govern how healthcare algorithms are paid for and deployed, so who gets private access to shape them affects the entire industry.

Government

NIH Plans National Push on Personalized Cancer Vaccines

The NIH plans a December public-private partnership to accelerate development of personalized cancer vaccines, per a New York Times report.

Why it matters: A federally coordinated effort could accelerate a promising but fragmented field of custom cancer immunotherapies toward wider clinical use.